⌘K
Loading ticker…
As of 2026-08-24, Fulcrum Therapeutics, Inc. Common Stock (FULC) has a 3-month relative strength percentile of 9 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 32. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.7%, relative volume 0.46×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
FULC is held by 20 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $2M notional. Top 3 carry $5M.
Held by 44 ETFs · $54M across latest filings · largest weight 0.92% (XPH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $2M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| AVSC | 0.04% | $976K | −0.01 pp |
| VHTVanguard Health Care ETF | 0.00% | $780K | — |
| VFMO | 0.03% | $597K | −0.05 pp |
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.04% |
| $368K |
| −0.05 pp |
| VTWV | 0.02% | $307K | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $210K | — |
| AVUSAvantis U.S. Equity ETF | 0.00% | $76K | — |
| OMFS | 0.02% | $51K | −0.03 pp |
Showing 10 of 20 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | FULC Jan avg: 14.83% median: 0.92% win: 50% σ: 40.02% n: 4 2022-04-12 → 2026-07-31 | FULC Feb avg: -10.48% median: -15.62% win: 25% σ: 38.97% n: 4 2022-04-12 → 2026-07-31 | FULC Mar avg: -22.15% median: -14.12% win: 0% σ: 21.19% n: 4 2022-04-12 → 2026-07-31 | FULC Apr avg: -11.54% median: -12.28% win: 20% σ: 29.72% n: 5 2022-04-12 → 2026-07-31 | FULC May avg: 13.71% median: 8.80% win: 60% σ: 39.04% n: 5 2022-04-12 → 2026-07-31 | FULC Jun avg: -15.58% median: -21.02% win: 40% σ: 26.80% n: 5 2022-04-12 → 2026-07-31 | FULC Jul avg: 16.21% median: 15.76% win: 60% σ: 21.28% n: 5 2022-04-12 → 2026-07-31 | FULC Aug avg: 14.76% median: 11.07% win: 50% σ: 25.01% n: 4 2022-04-12 → 2026-07-31 (current) | FULC Sep avg: -6.66% median: -5.19% win: 50% σ: 42.63% n: 4 2022-04-12 → 2026-07-31 | FULC Oct avg: -16.42% median: -14.75% win: 0% σ: 11.26% n: 4 2022-04-12 → 2026-07-31 | FULC Nov avg: 25.48% median: 24.12% win: 100% σ: 4.45% n: 4 2022-04-12 → 2026-07-31 | FULC Dec avg: 18.09% median: 14.18% win: 100% σ: 17.12% n: 4 2022-04-12 → 2026-07-31 |